JP2012503668A5 - - Google Patents

Download PDF

Info

Publication number
JP2012503668A5
JP2012503668A5 JP2011529222A JP2011529222A JP2012503668A5 JP 2012503668 A5 JP2012503668 A5 JP 2012503668A5 JP 2011529222 A JP2011529222 A JP 2011529222A JP 2011529222 A JP2011529222 A JP 2011529222A JP 2012503668 A5 JP2012503668 A5 JP 2012503668A5
Authority
JP
Japan
Prior art keywords
formulation
lung
droplets
microns
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011529222A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012503668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/058217 external-priority patent/WO2010036798A1/en
Publication of JP2012503668A publication Critical patent/JP2012503668A/ja
Publication of JP2012503668A5 publication Critical patent/JP2012503668A5/ja
Pending legal-status Critical Current

Links

JP2011529222A 2008-09-25 2009-09-24 肺深部へのトレプロスチニルの肺送達 Pending JP2012503668A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10001708P 2008-09-25 2008-09-25
US61/100,017 2008-09-25
PCT/US2009/058217 WO2010036798A1 (en) 2008-09-25 2009-09-24 Deep lung pulmonary delivery of treprostinil

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015044671A Division JP2015129177A (ja) 2008-09-25 2015-03-06 肺深部へのトレプロスチニルの肺送達

Publications (2)

Publication Number Publication Date
JP2012503668A JP2012503668A (ja) 2012-02-09
JP2012503668A5 true JP2012503668A5 (enExample) 2012-11-08

Family

ID=42060085

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011529222A Pending JP2012503668A (ja) 2008-09-25 2009-09-24 肺深部へのトレプロスチニルの肺送達
JP2015044671A Pending JP2015129177A (ja) 2008-09-25 2015-03-06 肺深部へのトレプロスチニルの肺送達

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015044671A Pending JP2015129177A (ja) 2008-09-25 2015-03-06 肺深部へのトレプロスチニルの肺送達

Country Status (7)

Country Link
US (1) US20120177693A1 (enExample)
EP (1) EP2330893A4 (enExample)
JP (2) JP2012503668A (enExample)
KR (1) KR20110081204A (enExample)
CN (1) CN102164487A (enExample)
CA (1) CA2737350A1 (enExample)
WO (1) WO2010036798A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007134292A2 (en) 2006-05-15 2007-11-22 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler
DE102006026786A1 (de) 2006-06-07 2007-12-13 Joachim Kern Dosierinhalator
US8734845B2 (en) 2009-06-12 2014-05-27 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
DE102009031274A1 (de) * 2009-06-30 2011-01-13 Justus-Liebig-Universität Giessen Liposomen zur pulmonalen Applikation
EP2338520A1 (de) 2009-12-21 2011-06-29 Ludwig Maximilians Universität Konjugat mit Zielfindungsligand und dessen Verwendung
EP2547341B1 (en) 2010-03-15 2016-09-14 United Therapeutics Corporation Treatment for pulmonary hypertension
CN103379907B (zh) 2011-01-13 2018-01-09 塞法姆公司 增强造血干细胞移入的方法
CA2906817C (en) 2013-03-15 2022-01-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
EP3021834A1 (en) 2013-07-18 2016-05-25 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
DK3060041T3 (da) 2013-10-25 2021-03-22 Insmed Inc Prostacyclinforbindelser
TWI685348B (zh) * 2014-05-08 2020-02-21 美國禮來大藥廠 速效胰島素組合物
CA2967385C (en) 2014-11-18 2023-05-16 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
WO2017132601A1 (en) * 2016-01-29 2017-08-03 Mannkind Corporation Dry powder inhaler
IL262720B2 (en) 2016-05-05 2024-06-01 Liquidia Tech Inc Dry powder treprostinil for the treatment of pulmonary hypertension
US10799653B2 (en) 2017-01-09 2020-10-13 United Therapeutics Corporation Aerosol delivery device and method for manufacturing and operating the same
SG11202011045VA (en) * 2018-05-07 2020-12-30 Pharmosa Biopharm Inc Pharmaceutical composition for controlled release of treprostinil
EP3962472A4 (en) 2019-04-29 2023-01-25 Insmed Incorporated DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF
US20210022994A1 (en) 2019-07-22 2021-01-28 Lupin Holdings, B.V. Sustained release trepostinil-compound microparticle compositions
KR20230011929A (ko) 2020-04-17 2023-01-25 유나이티드 쎄러퓨틱스 코포레이션 간질성 폐 질환의 치료에 사용하기 위한 트레프로스티닐

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
US20040063912A1 (en) * 2002-03-15 2004-04-01 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
CN101090714A (zh) * 2004-07-26 2007-12-19 康泽里克斯公司 通过吸入伊洛前列素和微粒制剂治疗肺动脉高血压症
WO2007134292A2 (en) * 2006-05-15 2007-11-22 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler

Similar Documents

Publication Publication Date Title
JP2012503668A5 (enExample)
WO2009112274A3 (en) Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
WO2009112273A3 (en) Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
JP2016534153A5 (enExample)
HRP20130052T1 (hr) Lijeäśenje respiratorne bolesti
UA107499C2 (uk) Склад сухого порошку, який містить антимускариновий засіб
JP2013224331A5 (enExample)
JP2011201907A5 (enExample)
JP2013540123A5 (enExample)
JP2011144201A5 (enExample)
EA201401354A1 (ru) Новая дозированная форма и препарат, содержащий абедитерол
WO2013021199A3 (en) Eutectic mixture for pulmonary administration
JP2010132695A5 (enExample)
JP2014503593A5 (enExample)
JP2013515022A5 (enExample)
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
JP2010508365A5 (enExample)
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
RU2007119721A (ru) Частицы для лечения легочной инфекции
EP2682097A3 (en) Dry Powder Inhalers Comprising A Carrier Other Than Lactose
JP2008533072A5 (enExample)
HRP20120286T1 (hr) Kombinacija antikolinergika i inhibitora fosfodiesteraze tip 4 za liječenje respiratornih bolesti
PE20142441A1 (es) Nueva dosificacion y formulacion
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка